Metastatic cells are able to repurpose this E-selectin binding as a means to promote metastasis; in mouse models, metastatic breast cancer cells were shown to undergo MET upon binding with E-selectin expressed on the vascular endothelium [100]. Here, SELE is linked to breast cancer.